Home / Inspections / 1002180

FDA Inspection 1002180 — Biomat USA Inc

Biomat USA Inc — FEI 1073354

The FDA completed an inspection of Biomat USA Inc on February 17, 2017 in Birmingham, AL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
February 17, 2017
Fiscal Year
2017
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Birmingham, AL (United States)

Facility

Other inspections at this facility

  • 1119012 (NAI Wed Jan 15 2020 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 932111 (NAI Tue Jun 23 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 774866 (NAI Fri Mar 30 2012 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 651287 (NAI Fri Mar 12 2010 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources